Safety and patient perception of an insulin pen with simple memory function for children and adolescents with type 1 diabetes--the REMIND study.

  • Adolfsson P
  • Veijola R
  • Huot C
 et al. 
  • 10


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


NovoPen Echo * is a durable pediatric insulin pen incorporating half-unit dosing starting at 0.5 units and a last-dose memory function. The REMIND † (Rating the Effects of Memory function in pediatric INsulin Devices) study primarily examined the safety of this new device by collecting data on technical complaints (TCs) related to adverse reactions (ARs) during use in a clinical setting.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Peter Adolfsson

  • Riitta Veijola

  • Celine Huot

  • Helle Doré Hansen

  • Jacob Bo Lademann

  • Moshe Phillip

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free